Literature DB >> 15525738

Medical treatment of peripheral arterial disease: a comprehensive review.

Athanasios Stoyioglou1, Michael R Jaff.   

Abstract

Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis that affects more than 10 million people in the United States. The risk factors associated with PAD are similar to those found in patients with coronary artery disease and cerebrovascular disease. Medical therapy of PAD must include modification of cardiovascular risk factors with application of strict secondary prevention guidelines. For improvement in quality of life, a structured exercise rehabilitation program remains the most effective noninterventional treatment strategy, but it is difficult to employ from economic and patient-compliance perspectives. Newer pharmacologic therapies have demonstrated efficacy in patients with intermittent claudication. Emerging strategies for management of these patients include revascularization and maximal medical therapy for improvement of physical function as well as reduction in risk for subsequent major cardiovascular events. This article will review the clinical data supporting aggressive medical interventions for patients with PAD.

Entities:  

Mesh:

Year:  2004        PMID: 15525738     DOI: 10.1097/01.RVI.0000137978.15352.C6

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  19 in total

Review 1.  Statin therapy in cardiovascular diseases other than atherosclerosis.

Authors:  Dominique Beaudry; Kenneth E Stone; Suzanne Wetherold; John Hemphill; Dat Do; John McClish; Robert Chilton
Journal:  Curr Atheroscler Rep       Date:  2007-01       Impact factor: 5.113

Review 2.  Modulating the vascular response to limb ischemia: angiogenic and cell therapies.

Authors:  John P Cooke; Douglas W Losordo
Journal:  Circ Res       Date:  2015-04-24       Impact factor: 17.367

3.  Lifelong limb preservation: A patient-centered description of lower extremity arterial reconstruction outcomes.

Authors:  Katie E Shean; Peter A Soden; Marc L Schermerhorn; Sara L Zettervall; Sarah E Deery; Jeremy D Darling; Allen Hamdan; Frank W LoGerfo
Journal:  J Vasc Surg       Date:  2017-05-11       Impact factor: 4.268

4.  VEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.

Authors:  Florence T H Wu; Marianne O Stefanini; Feilim Mac Gabhann; Christopher D Kontos; Brian H Annex; Aleksander S Popel
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-04-09       Impact factor: 4.733

5.  Periodontitis deteriorates peripheral arterial disease in Japanese population via enhanced systemic inflammation.

Authors:  Norio Aoyama; Jun-Ichi Suzuki; Naho Kobayashi; Tomoya Hanatani; Norihiko Ashigaki; Asuka Yoshida; Yuka Shiheido; Hiroki Sato; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Issei Komuro; Yuichi Izumi; Mitsuaki Isobe
Journal:  Heart Vessels       Date:  2017-05-31       Impact factor: 2.037

6.  Critical limb ischemia.

Authors:  Andres Schanzer; Michael S Conte
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-04-14

7.  Treatment for critical lower limb ischemia in elderly patients.

Authors:  Kevin de Leur; Michiel L P van Zeeland; Gwan H Ho; Hans G W de Groot; Eelco J Veen; Lijckle van der Laan
Journal:  World J Surg       Date:  2012-12       Impact factor: 3.352

Review 8.  Current therapies and investigational drugs for peripheral arterial disease.

Authors:  Jun-Ichi Suzuki; Munehisa Shimamura; Hiroyuki Suda; Kouji Wakayama; Hidetoshi Kumagai; Yuichi Ikeda; Hiroshi Akazawa; Mitsuaki Isobe; Issei Komuro; Ryuichi Morishita
Journal:  Hypertens Res       Date:  2015-12-03       Impact factor: 3.872

9.  Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data.

Authors:  Andres Schanzer; Jessica Mega; Judith Meadows; Russell H Samson; Dennis F Bandyk; Michael S Conte
Journal:  J Vasc Surg       Date:  2008-12       Impact factor: 4.268

10.  Reduced Physical Activity Levels in Children after a First Episode of Acute Venous Thromboembolism.

Authors:  Ayesha Zia; Zhuo Yang; Song Zhang; Tony Babb
Journal:  J Pediatr       Date:  2020-04       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.